2017
Feasibility, acceptability and clinical utility of the Cultural Formulation Interview: Mixed-methods results from the DSM-5 international field trial
Lewis-Fernández R, Aggarwal NK, Lam PC, Galfalvy H, Weiss MG, Kirmayer LJ, Paralikar V, Deshpande SN, Díaz E, Nicasio AV, Boiler M, Alarcón RD, Rohlof H, Groen S, van Dijk RC, Jadhav S, Sarmukaddam S, Ndetei D, Scalco MZ, Bassiri K, Aguilar-Gaxiola S, Ton H, Westermeyer J, Vega-Dienstmaier JM. Feasibility, acceptability and clinical utility of the Cultural Formulation Interview: Mixed-methods results from the DSM-5 international field trial. The British Journal Of Psychiatry 2017, 210: 290-297. PMID: 28104738, DOI: 10.1192/bjp.bp.116.193862.Peer-Reviewed Original ResearchConceptsCultural Formulation InterviewClinical utilityDSM-5 Cultural Formulation InterviewClinician-assessed outcomesRoutine clinical practiceFeasibility ratingsMixed-methods evaluationPatient ratingsClinical practiceTrial dataDiagnostic InterviewClinical toolInternational field trialDiagnostic assessmentPatientsDSM-5CliniciansCultural assessment toolMixed methods resultsAssessment toolDiagnostic sessionMixed methods dataQualitative interviewsSessionsAcceptability
2010
Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations
Escobar JI, Cook B, Chen CN, Gara MA, Alegría M, Interian A, Diaz E. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. Journal Of Psychosomatic Research 2010, 69: 1-8. PMID: 20630257, PMCID: PMC2905311, DOI: 10.1016/j.jpsychores.2010.01.001.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAnxiety DisordersAsianCommunity Health ServicesComorbidityCross-Cultural ComparisonDepressive DisorderFemaleHispanic or LatinoHumansMaleMental DisordersMiddle AgedSomatoform DisordersStatistics as TopicSubstance-Related DisordersUtilization ReviewWhite PeopleYoung AdultConceptsGeneral physical symptomsPhysical symptomsService useSomatic symptomsCommunity populationUse of servicesPsychological distressCommon mental disordersUnexplained physical symptomsSubstance use disordersSignificant independent effectUnadjusted comparisonsPsychiatric disordersUse disordersMental disordersSymptomsMUPSSignificant predictorsIndependent effectsMedical explanationDisordersMultivariate regressionRegression analysisOne-thirdDistress
2009
Inconsistencies in Diagnosis and Symptoms Among Bilingual and English-Speaking Latinos and Euro-Americans
Díaz E, Miskemen T, Vega WA, Gara M, Wilson DR, Lesser I, Escamilla M, Neighbors HW, Arndt S, Strakowski S. Inconsistencies in Diagnosis and Symptoms Among Bilingual and English-Speaking Latinos and Euro-Americans. Psychiatric Services 2009, 60: 1379-1382. PMID: 19797380, DOI: 10.1176/ps.2009.60.10.1379.Peer-Reviewed Original ResearchConceptsMonolingual EnglishBilingual LatinosEuro-AmericansMajor depressionSecond languageCentral research questionEuro-American patientsMajor mental disordersEnglishMedical record informationStructured diagnostic interviewAccuracy of diagnosisLatino patientsSevere depressionPatient profilesClinical carePsychotic symptomsClinical sitesMental disordersClinical diagnosisDiagnostic InterviewLatinosDiagnosisDiagnostic patternsResearch questions
2005
Effects of Ethnicity on Psychotropic Medications Adherence
Diaz E, Woods SW, Rosenheck RA. Effects of Ethnicity on Psychotropic Medications Adherence. Community Mental Health Journal 2005, 41: 521-537. PMID: 16142536, DOI: 10.1007/s10597-005-6359-x.Peer-Reviewed Original ResearchConceptsCommunity mental health centerMedication adherence ratesAdherence ratesHigh adherenceLow medication adherence ratesAfrican AmericansPsychotropic medication adherenceMental health centersMedication adherenceHealth centersLow adherenceDepressive symptomsEffect of ethnicityMonolingual HispanicsOlder ageAdherenceSignificant predictorsPast treatmentCaucasiansFurther studiesHispanicsMore yearsSymptoms
2004
Adherence to conventional and atypical antipsychotics after hospital discharge.
Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherence to conventional and atypical antipsychotics after hospital discharge. The Journal Of Clinical Psychiatry 2004, 65: 354-60. PMID: 15096075, DOI: 10.4088/jcp.v65n0311.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntipsychotic AgentsBenzodiazepinesDiagnostic and Statistical Manual of Mental DisordersDrug Administration ScheduleFeasibility StudiesFemaleHospitalizationHospitals, PsychiatricHumansMaleOlanzapinePatient CompliancePatient DischargePilot ProjectsProspective StudiesRisperidoneSchizophreniaConceptsConventional antipsychoticsMedication adherenceDose frequencyHospital dischargeAtypical antipsychoticsSchizoaffective disorderUsual care providersBetter medication adherenceMedication adherence ratesSeverity of illnessShort-term adherenceDSM-IV diagnosisDiagnosis of schizophreniaAdherence advantageElectronic adherence monitorsOral antipsychoticsUsual careProspective studyAdherence ratesOutcome measuresMedication analysisAdherence monitorsAntipsychoticsCare providersInpatient unit
2003
Best Practices: Racial and Ethnic Effects on Antipsychotic Prescribing Practices in a Community Mental Health Center
Woods SW, Sullivan MC, Neuse EC, Diaz E, Baker CB, Madonick SH, Griffith EE, Steiner JL. Best Practices: Racial and Ethnic Effects on Antipsychotic Prescribing Practices in a Community Mental Health Center. Psychiatric Services 2003, 54: 177-179. PMID: 12556597, DOI: 10.1176/appi.ps.54.2.177.Peer-Reviewed Original Research
2001
Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
Diaz E, Levine HB, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, Woods SW. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. Journal Of Psychiatry And Neuroscience 2001, 26: 325-9. PMID: 11590972, PMCID: PMC167186.Peer-Reviewed Original ResearchConceptsMedication Event Monitoring SystemEvent Monitoring SystemFirst monthMedication complianceSchizoaffective disorderCompliance rateTypical antipsychotic treatmentMean compliance ratePsychiatric inpatient hospitalHospital readmission dataElectronic monitoring devicesConsecutive patientsMedication regimensMonth 3Antipsychotic treatmentReadmission dataInpatient hospitalPatientsMEMS capsSchizophrenic disordersBottle openingHospitalSchizophreniaMonthsDisordersPerceived Needs and Service Use of Spanish Speaking Monolingual Patients Followed at a Hispanic Clinic
Diaz E, Prigerson H, Desai R, Rosenheck R. Perceived Needs and Service Use of Spanish Speaking Monolingual Patients Followed at a Hispanic Clinic. Community Mental Health Journal 2001, 37: 335-346. PMID: 11482751, DOI: 10.1023/a:1017552608517.Peer-Reviewed Original ResearchMeSH KeywordsAdultCommunication BarriersCommunity Mental Health CentersConnecticutCross-Sectional StudiesCultural DiversityEducational StatusFemaleHealth Care SurveysHealth Services, IndigenousHispanic or LatinoHumansLanguageMaleMiddle AgedNeeds AssessmentPatient CompliancePsychotropic DrugsSurveys and QuestionnairesConceptsMonolingual patientsPhysical health care providersMental health centersHealth care providersClinic patientsHealth centersAdditional interventionsCare providersService useHealth needsSociodemographic characteristicsNon-HispanicsPatientsClinicPerceived NeedsHispanicsPersistent effectsLow levelsBetter accessGreat needMedicationsMore difficultyLanguage barriers
2000
Effects of Divalproex Versus Lithium on Length of Hospital Stay Among Patients With Bipolar Disorder
Dalkilic A, Diaz E, Baker C, Pearsall H, Woods S. Effects of Divalproex Versus Lithium on Length of Hospital Stay Among Patients With Bipolar Disorder. Psychiatric Services 2000, 51: 1184-1186. PMID: 10970927, DOI: 10.1176/appi.ps.51.9.1184.Peer-Reviewed Original ResearchConceptsLength of stayBipolar disorderConnecticut Mental Health CenterLength of hospitalProspective Randomized StudyMental health centersDosages of neurolepticsRandomized studyBlood levelsMedical recordsHealth centersPractice guidelinesDivalproexStay variablesDisordersSignificant differencesPatientsStayDemographic variablesDosageDiagnostic variablesMonotherapyNeurolepticsInpatientsHospitalCharacteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia
Woods SW, Ziedonis DM, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 2000, 51: 79-84. PMID: 10647137, DOI: 10.1176/ps.51.1.79.Peer-Reviewed Original ResearchConceptsSubstance use disordersTreatment of schizophreniaUse disordersAdministrative databasesEfficacy trialsTrial participantsDual diagnosisConcurrent substance use disordersCommunity mental health centerTreatment Efficacy TrialCharacteristics of patientsPoor treatment outcomesMental health centersCharacteristics of participantsMedical comorbiditiesMedication trialsTypes of trialsMale genderHealth centersService utilizationTreatment outcomesBetter outcomesPatientsTreatment efficacyYounger age